Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population
Launched by AMERICAN COCHLEAR IMPLANT ALLIANCE · Feb 28, 2014
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
Informed Consent will be obtained prior to enrollment in the study, and will include an interview to discuss study expectations, potential risks and benefits and the study evaluation schedule. The Informed Consent Form may be taken home and reviewed by the candidate and the candidate will be given the opportunity to ask questions about it and/or the study prior to signing the form. The candidate will then be given a copy of the signed Informed Consent Form.
The Informed Consent Forms will include a detailed list of procedures included in the pre-operative evaluation process. The Informed C...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Sixty-five years of age or older at the time of the study and CMS-eligible as primary source of medical insurance coverage.
- • Bilateral moderate to profound hearing loss in the low frequencies (up to 1000 Hz) and profound sensorineural hearing loss in the high frequencies (3000 Hz and above).
- • Preoperative aided sentence score in quiet greater than or equal to 40% correct but less than or equal to 60% correct in the best aided condition on recorded AzBio sentences.
- • English spoken as the primary language.
- Exclusion Criteria:
- • Congenital hearing loss (for the purpose of this study, onset pror to 2 years-of-age).
- • Preoperative aided sentence score less than 40% or greater than 60% correct in the best aided condition on AzBio sentences in quiet
- • Ossification, absence of cochlear development or any other cochlear anomaly that might prevent complete insertion of the electrode array.
- • Hearing loss of neural or central origin (e.g., deafness due to lesions on the acoustic nerve or central auditory pathway).
- • Active middle-ear infection.
- • The audiologist and/or surgeon will review the study protocol with the patient prior to having him/her sign the consent form. If the patient indicates he/she is unwilling or unable to comply with all investigational requirements, he/she will not be enrolled in the study.
- • Using best clinical judgment based on professional interaction with the patient and his/her family, the managing audiologist and surgeon will determine if there are any disabling cognitive limitations that would prevent the patient from providing reliable data for this study.
About American Cochlear Implant Alliance
The American Cochlear Implant Alliance (ACIA) is a leading nonprofit organization dedicated to advancing the field of cochlear implants through research, education, and advocacy. With a mission to improve the quality of life for individuals with hearing loss, ACIA fosters collaboration among clinicians, researchers, and patients to promote innovative clinical trials and evidence-based practices. By supporting scientific inquiry and disseminating knowledge, the ACIA plays a pivotal role in enhancing the understanding and accessibility of cochlear implant technology, ultimately striving to ensure that all individuals with hearing impairments can benefit from the latest advancements in auditory solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Boston, Massachusetts, United States
Charleston, South Carolina, United States
Columbus, Ohio, United States
Dallas, Texas, United States
Miami, Florida, United States
Los Angeles, California, United States
Englewood, Colorado, United States
Chicago, Illinois, United States
Iowa City, Iowa, United States
Baltimore, Maryland, United States
Ann Arbor, Michigan, United States
Kansas City, Missouri, United States
Saint Louis, Missouri, United States
Chapel Hill, North Carolina, United States
Philadelphia, Pennsylvania, United States
Nashville, Tennessee, United States
Seattle, Washington, United States
Milwaukee, Wisconsin, United States
Patients applied
Trial Officials
Teresa A Zwolan, Ph.D
Principal Investigator
University of Michigan & American Cochlear Implant Alliance
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials